XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies
- PMID: 23534729
- DOI: 10.7314/apjcp.2013.14.1.231
XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies
Abstract
Background: Published data regarding the association between xeroderma pigmentosum group D (XPD) Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility havew been inconclusive. This meta-analysis was therefore performed toobtain a more precise estimation of any relationship.
Materials and methods: A comprehensive literature search was conducted to identify all case-control studies of Lys751Gln and Asp312Asn polymorphisms and susceptibility to gastric cancer. Summary odds ratios (ORs) and its 95% confidence intervals (95% CIs) were calculated using a random-effects model with the software STATA (version10.0).
Results: A total of 12 case-control studies including 3,147 cases and 4,736 controls were included. Overall, no significant associations were found in some models (for Lys751Gln: Lys/Gln vs Lys/Lys: OR=1.144, 95% CI=0.851-1.541, Gln/Gln vs Lys/Lys: OR=1.215, 95% CI = 0.740-1.955, dominant model: OR=1.137, 95% CI=0.818-1.582; recessive model: OR=1.123, 95% CI=0.765-1.650; for Asp312Asn: Asp/Asn vs Asp/Asp: OR=1.180, 95% CI=0.646-2.154, dominant model: OR=1.380, 95% CI = 0.812-2.346), but significantly elevated susceptibility was found for Asp312Asn polymorphism in some models (Asn/Asn vs Asp/Asp: OR=2.045, 95% CI=1.254-3.335, recessive model: OR=1.805, 95% CI =1.219-2.672 ), for the additive model, the XPD Lys751Gln and Asp312Asn polymorphisms were not significantly associated with gastric cancer susceptibility. In stratified analyses, significantly elevated susceptibility was found for some models in the Chinese population.
Conclusion: This meta-analysis suggested the XPD Asp312Asn polymorphism might be a potential biomarker of gastric cancer susceptibility in overall population, while both XPD Lys751Gln and Asp312Asn polymorphisms might be risk factors of gastric cancer susceptibility in Chinese.
Similar articles
-
Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.World J Gastroenterol. 2014 Nov 28;20(44):16765-73. doi: 10.3748/wjg.v20.i44.16765. World J Gastroenterol. 2014. PMID: 25469049 Free PMC article. Review.
-
Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.Int J Colorectal Dis. 2011 Oct;26(10):1257-64. doi: 10.1007/s00384-011-1222-8. Epub 2011 May 4. Int J Colorectal Dis. 2011. PMID: 21541661
-
XPD Lys751Gln and Asp312Asn polymorphisms and susceptibility to skin cancer: a meta-analysis of 17 case-control studies.Asian Pac J Cancer Prev. 2014;15(16):6619-25. doi: 10.7314/apjcp.2014.15.16.6619. Asian Pac J Cancer Prev. 2014. PMID: 25169498
-
Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.Gene. 2013 Nov 10;530(2):309-14. doi: 10.1016/j.gene.2013.08.053. Epub 2013 Aug 23. Gene. 2013. PMID: 23973729
-
Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.Medicine (Baltimore). 2014 Dec;93(29):e330. doi: 10.1097/MD.0000000000000330. Medicine (Baltimore). 2014. PMID: 25546681 Free PMC article.
Cited by
-
Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients.Cancer Epidemiol. 2016 Oct;44:161-166. doi: 10.1016/j.canep.2016.08.020. Epub 2016 Sep 5. Cancer Epidemiol. 2016. PMID: 27607585 Free PMC article.
-
XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.Tumour Biol. 2014 Jul;35(7):6335-41. doi: 10.1007/s13277-014-1835-y. Epub 2014 Mar 22. Tumour Biol. 2014. PMID: 24652592
-
XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma susceptibility: A meta-analysis of 11 case-control studies in an Asian population.Exp Ther Med. 2015 Jun;9(6):2406-2414. doi: 10.3892/etm.2015.2421. Epub 2015 Apr 14. Exp Ther Med. 2015. PMID: 26136996 Free PMC article.
-
The -786T > C polymorphism in the NOS3 gene is associated with increased cancer risk.Tumour Biol. 2014 Apr;35(4):3535-40. doi: 10.1007/s13277-013-1467-7. Epub 2014 Jan 24. Tumour Biol. 2014. PMID: 24464923
-
XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis.Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821990046. doi: 10.1177/1533033821990046. Technol Cancer Res Treat. 2021. PMID: 33517857 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials